Ava Kwong (A Kwong)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 27

Top Topics

Squamous Cell Carcinoma

Positive Breast Cancer

Ejection Fraction

Top Venues

Breast cancer research and treatment

Oncology and therapy

Breast cancer (Tokyo, Japan)

This page only lists publications with an associated author ORCID identifier.

Publications

Ava Kwong, David Shao Peng Tan, Jai Min Ryu, null null
Current practices and challenges in genetic testing and counseling for women with breast and ovarian cancer in Asia. Asia-Pacific journal of clinical oncology (2024)
Ava Kwong, Roland Leung, Tsz Ching Chan, Anvi Khandelwal, Kshama Mishra, Min Huang
Cost-effectiveness of Pembrolizumab in Combination with Chemotherapy as Neoadjuvant Treatment and Continued as a Single Agent Adjuvant Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer in Hong Kong. Oncology and therapy 12 (3) (2024)
Ava Kwong, Cecilia Y S Ho, Chun Hang Au, Edmond Shiu-Kwan Ma
Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients. Cancers 16 (14) (2024)
Ava Kwong, Cecilia Y S Ho, Chun Hang Au, Edmond Shiu-Kwan Ma
Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients. Cancers 16 (14) (2024)
Ava Kwong, Cecilia Y S Ho, Chun Hang Au, Edmond Shiu-Kwan Ma
Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients. Cancers 16 (14) (2024)
Seock-Ah Im, Javier Cortes, David W Cescon, Mastura Md Yusof, Hiroji Iwata, Norikazu Masuda, Toshimi Takano, Chiun-Sheng Huang, Chi-Feng Chung, Koichiro Tsugawa, Yeon Hee Park, Koji Matsumoto, Kenichi Inoue, Ava Kwong, Sherene Loi, Wei Fu, Wilbur Pan, Vassiliki Karantza, Hope S Rugo, Peter Schmid
Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC. NPJ breast cancer 10 (1) (2024)
Ava Kwong, Roland Leung, Tsz Ching Chan, Anvi Khandelwal, Kshama Mishra, Min Huang
Cost-effectiveness of Pembrolizumab in Combination with Chemotherapy as Neoadjuvant Treatment and Continued as a Single Agent Adjuvant Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer in Hong Kong. Oncology and therapy 12 (3) (2024)
Ava Kwong, Roland Leung, Tsz Ching Chan, Anvi Khandelwal, Kshama Mishra, Min Huang
Cost-effectiveness of Pembrolizumab in Combination with Chemotherapy as Neoadjuvant Treatment and Continued as a Single Agent Adjuvant Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer in Hong Kong. Oncology and therapy 12 (3) (2024)
Ava Kwong, Roland Leung, Tsz Ching Chan, Anvi Khandelwal, Kshama Mishra, Min Huang
Cost-effectiveness of Pembrolizumab in Combination with Chemotherapy as Neoadjuvant Treatment and Continued as a Single Agent Adjuvant Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer in Hong Kong. Oncology and therapy (2024)
Ava Kwong, Cecilia Yuen Sze Ho, Vivian Yvonne Shin, Ada Tsui Lin Ng, Tsun Leung Chan, Edmond Shiu Kwan Ma
Molecular characteristics of Asian male BRCA-related cancers. Breast cancer research and treatment (2023)
Ava Kwong, Cecilia Yuen Sze Ho, Vivian Yvonne Shin, Ada Tsui Lin Ng, Tsun Leung Chan, Edmond Shiu Kwan Ma
Molecular characteristics of Asian male BRCA-related cancers. Breast cancer research and treatment 198 (2) (2023)
Ava Kwong, Cecilia Yuen Sze Ho, Vivian Yvonne Shin, Ada Tsui Lin Ng, Tsun Leung Chan, Edmond Shiu Kwan Ma
Molecular characteristics of Asian male BRCA-related cancers. Breast cancer research and treatment 198 (2) (2023)
Ava Kwong, Cecilia Y S Ho, Wing-Pan Luk, Ling-Hiu Fung, Chun-Hang Au, Edmond Shiu-Kwan Ma
Effect on Germline Mutation Rate in a High-Risk Chinese Breast Cancer Cohort after Compliance with The National Comprehensive Cancer Network (NCCN) 2023 v.1 Testing Criteria. Cancers 15 (9) (2023)
Ava Kwong, Cecilia Y S Ho, Wing-Pan Luk, Ling-Hiu Fung, Chun-Hang Au, Edmond Shiu-Kwan Ma
Effect on Germline Mutation Rate in a High-Risk Chinese Breast Cancer Cohort after Compliance with The National Comprehensive Cancer Network (NCCN) 2023 v.1 Testing Criteria. Cancers 15 (9) (2023)
Ava Kwong, Cecilia Yuen Sze Ho, Vivian Yvonne Shin, Ada Tsui Lin Ng, Tsun Leung Chan, Edmond Shiu Kwan Ma
Molecular characteristics of Asian male BRCA-related cancers. Breast cancer research and treatment 198 (2) (2023)
Vivian Man, Wing-Pan Luk, Ling-Hiu Fung, Ava Kwong
The role of pre-operative axillary ultrasound in assessment of axillary tumor burden in breast cancer patients: a systematic review and meta-analysis. Breast cancer research and treatment 196 (2) (2022)
Ava Kwong, Cecilia Yuen Sze Ho, Vivian Yvonne Shin, Chun Hang Au, Wing Pan Luk, Ling Hiu Fung, Tsun-Leung Chan, Karen Kar Loen Chan, Hextan Yuen Sheung Ngan, Edmond Shiu Kwan Ma
Germline mutations in Chinese ovarian cancer with or without breast cancer. Molecular genetics & genomic medicine 10 (7) (2022)
I W Cheuk, J Chen, M Siu, J C Ho, S S Lam, V Y Shin, Ava Kwong
Resveratrol enhanced chemosensitivity by reversing macrophage polarization in breast cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2021)
Kathy S M Leung, Gabriel M Leung, Irene Oi-Ling Wong, Xiao-Ou Shu, Wei Zheng, Wanqing Wen, Ui Soon Khoo, Roger Ngan, Ava Kwong, Gabriel M Leung
Using Risk Stratification to Optimize Mammography Screening in Chinese Women. JNCI cancer spectrum 5 (4) (2021)
Annie Tsz-Wai Chu, Desiree Man-Sik Tse, Dacita To Ki Suen, Ava Kwong
Baseline knowledge and receptiveness to genetic testing for hereditary breast and ovarian cancer syndromes in Chinese high-risk females. Journal of community genetics 12 (3) (2021)
Ava Kwong, Michael Tiong-Hong Co, Clement Chen, Arnold Wu
Prospective clinical trial on high-intensity focused ultrasound for the treatment of breast fibroadenoma. The breast journal 27 (3) (2021)
Sherko Kuemmel, Mario Campone, Delphine Loirat, Rafael Lopez Lopez, J Thaddeus Beck, Michelino De Laurentiis, Seock-Ah Im, Sung-Bae Kim, Ava Kwong, Guenther G Steger, Esther Zamora Adelantado, Fran Ois P Duhoux, Richard Greil, Irene Kuter, Yen-Shen Lu, Ariadna Tibau, Mustafa Özgüroğlu, Claus-Jürgen Scholz, Christian F Singer, Estela Vega, Pauline Wimberger, Claudio Zamagni, Xuan-Mai Couillebault, Liqiong Fan, Nelson Guerreiro, Jennifer Mataraza, Janna Sand-Dejmek, Arlene Chan
A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Michael Tiong-Hong Co, Andrea Lee, Ava Kwong
Delayed presentation, diagnosis, and psychosocial aspects of male breast cancer. Cancer medicine 9 (10) (2020)
Yuk-Kwan Chang, Clement Tzu-Hsin Chen, Min Wang, Yong Yang, Bonita Mark, Ai-Qiu Zheng, Ava Kwong
Could ductoscopy alleviate the need of microdochectomy in pathological nipple discharge? Breast cancer (Tokyo, Japan) 27 (4) (2020)
Yuk-Kwan Chang, Michael Co, Ava Kwong
Conversion rate from mastectomy to breast conservation after neoadjuvant dual target therapy for HER2-positive breast cancer in the Asian population. Breast cancer (Tokyo, Japan) 27 (3) (2020)
Ava Kwong, Vivian Yvonne Shin, Cecilia Y S Ho, Chun Hang Au, Thomas P Slavin, Jeffrey N Weitzel, Tsun-Leung Chan, Edmond S K Ma
Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients. BMC cancer 20 (1) (2020)
Josephine Mun-Yee Ko, Lvwen Ning, Xue-Ke Zhao, Annie Wai Yeeng Chai, Lisa Chan Lei, Sheyne Sta Ana Choi, Lihua Tao, Simon Law, Ava Kwong, Nikki Pui-Yue Lee, Kin-Tak Chan, Anthony Lo, Xin Song, Pei-Nan Chen, Yun-Li Chang, Li Dong Wang, Maria Li Lung
BRCA2 loss-of-function germline mutations are associated with esophageal squamous cell carcinoma risk in Chinese. International journal of cancer 146 (4) (2019)